Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$167K Sell
1,683
-204
-11% -$21K 0.05% 174
2024
Q3
$214K Sell
1,887
-397
-17% -$47.2K 0.06% 170
2024
Q2
$283K Sell
2,284
-17
-0.7% -$2.19K 0.09% 139
2024
Q1
$304K Buy
2,301
+111
+5% +$13.7K 0.09% 135
2023
Q4
$239K Buy
2,190
+193
+10% +$20K 0.09% 161
2023
Q3
$206K Sell
1,997
-193
-9% -$20.8K 0.08% 164
2023
Q2
$253K Buy
2,190
+815
+59% +$92.5K 0.1% 146
2023
Q1
$146K Buy
1,375
+1,085
+374% +$117K 0.06% 188
2022
Q4
$32.2K Sell
290
-30
-9% -$3.07K 0.02% 197
2022
Q3
$27.6K Buy
320
+33
+11% +$2.95K 0.02% 194
2022
Q2
$26.1K Buy
287
+2
+0.7% +$177 0.02% 209
2022
Q1
$23.4K Buy
+285
New +$22.5K 0.01% 214

Other funds holding MRK

WR Wealth Planners's MRK Position: Q4 2024 in Review

WR Wealth Planners reduced its Merck (MRK) stake by 11% in Q4 2024, selling an estimated $21K and leaving 1,683 shares worth $167K. The position accounts for 0.05% of the portfolio, ranked #174.

WR Wealth Planners first reported a position in MRK in Q1 2022 and has held it in 12 quarters since. The position peaked at $304K in Q1 2024. 3,608 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • WR Wealth Planners held 1,683 shares of Merck worth $167K as of Q4 2024.
  • WR Wealth Planners sold 204 Merck shares in Q4 2024, an estimated $21K.
  • Merck made up 0.05% of WR Wealth Planners's portfolio in Q4 2024, its #174 holding.
  • WR Wealth Planners first reported a position in Merck in Q1 2022 and has held it in 12 quarters since.
  • WR Wealth Planners's Merck position peaked at $304K in Q1 2024.
  • 3,608 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on WR Wealth Planners's 13F filing for Q4 2024, filed 5 Feb 2025.